Extended lymphadenectomy does not improve survival in muscle-invasive bladder cancer
1. In this randomized controlled trial, extended lymphadenectomy did not improve disease-free or overall survival in patients with muscle-invasive bladder...
Urology
Reports of high-impact urology studies by medical professionals
MRI-informed biopsy recommendation reduces overdiagnosis in prostate cancer screening
1. In this randomized controlled trial of men aged 50 to 60, forgoing prostate biopsies in those with elevated PSA...
Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients
1. In a retrospective analysis of 59,875 patients with metastatic prostate cancer, varying prognoses were found primarily depending on the...
Pelvic floor yoga not superior to general muscle strengthening for urinary incontinence in women
1. In this randomized controlled trial, middle-aged and older women who participated in pelvic yoga had similar changes in urinary...
bpMRI associated with higher false positive rate than PSA for prostate cancer screening
1. In this decision model analysis, biparametric MRI (bpMRI) testing led to an increased rate of overdiagnosis and false positives...
Short-term androgen deprivation therapy does not improve survival in patients receiving postoperative radiotherapy for prostate cancer
1. There was no significant difference in metastasis-free survival between the ADT and non-ADT groups over 10 years. 2. Adverse...
Personalized therapy does not reduce hospitalization in chronic kidney disease
1. In this randomized controlled trial, algorithmic identification based on electronic health records (EHRs) and practice facilitators did not reduce...
Plant-based diets may be associated with slower disease progression in men with prostate cancer
1. In a cohort of men with prostate cancer, disease progression was lower in men who had a higher intake...
Overall Survival Improved with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo group, with...
Gepotidacin safe and effective for treatment of uncomplicated urinary tract infections
1. Therapeutic response at days 10-13 was greater in the gepotidacin group compared to the nitrofurantoin group across both trials....
